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ABSTRACT 
In the late 1980s, a new hypervirulent and epidemic form of bovine viral diarrhoea virus (BVDV) 
infection appeared in North America. A similar but sporadic syndrome was later reported in 
Europe. To compare the pathogenic characters of the North American and European hypervirulent 
strains, we inoculated BVDV naïve calves with BVDV strains isolated from haemorrhagic syndromes 
originating in Belgium, France and the USA. The experimental procedure comprised daily clinical 
examination and measurement of blood and virological parameters. 
The American BVD890/256 strain induced severe thrombocytopaenia, profuse diarrhoea and 
pneumonia in all calves, indicating that hypervirulent BVDV could be the primary infectious agent 
of pneumonia. Interestingly, a strong correlation was observed between the intense viraemia and a 
decreased platelet count. None of the European strains tested induced significant pathological 
signs, although isolated from cases presenting haemorrhagic syndrome. 
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Bovine viral diarrhoea (BVD) was first identified in 1946 (Olafson et al., 1946), and for 40 years acute 
BVD virus (BVDV) infection has been associated with a contagious mild to inapparent disease of 
cattle with low mortalities. In 1953, Ramsey and Chivers described another condition of cattle, 
called mucosal disease (MD), resulting from the superinfection by a cytopathic BVDV strain from an 
animal persistently infected with an antigenically similar non-cytopathic BVDV strain (Liess et al., 
1974; Brownlie et al., 1984). Unlike BVD, MD was, however, described as a highly fatal but sporadic 
disease. In the late 1980s, a new hypervirulent form of BVD, characterized by high morbidity and 
mortality rates appeared in North America (Corapi et al., 1989). Affected cattle presented, besides 
severe hyperthermia and leucopenia, a thrombocytopaenia resulting in extensive bleeding lesions. 
Mortality rates sometimes reached over 30%, even in adults. Since that time, many cases of 
hypervirulent BVD have been reported in Canada and the USA (Rebhun et al., 1989; Pellerin et al., 
1994; Bolin & Ridpath, 1992), including a respiratory form (Carman et al., 1998; Odeon et al., 1999). 
Experimental reproduction of hypervirulence has been reported with some strains (Corapi et al., 
1989; Bolin & Ridpath, 1995; Odeon et al., 1999). 
Genetic sequencing of BVDV isolated from outbreaks of the hypervirulent form of the disease, 
revealed significant differences compared to conventional BVDV strains (Pellerin et al., 1994). 
These differences led to the segregation of BVDV strains (Ridpath et al., 1994) into a genotype 1, 
comprising many conventional strains and a genotype 2, which includes most hypervirulent 
strains. Phylogenic studies have shown that genotype 2 also comprises several low or moderately 
virulent strains. In Europe, the first clinical reports of haemorrhagic syndrome associated with 
BVDV were described in the early 1990s (Broes et al., 1992; Thiel, 1993; Lecomte et al., 1996). 
Clinical signs comprised hyperthermia, diarrhoea and extensive bleeding lesions associated with a 
severe thrombocytopaenia. The European cases, however, differed from North American ones by 
the absence of an epidemic character. Moreover, the experimental reproduction of severe disease 
by inoculation of a European BVDV strain has never been reported (Hamers et al., 1999). 
To compare the pathogenic character of the North American and European so-called hypervirulent 
strains, we inoculated BVDV naïve calves with BVDV strains isolated from cases of haemorrhagic 
syndrome, originating in Belgium, France and the USA. Only the American BVD890/256 strain 
reproduced a thrombocytopaenic syndrome. 
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MATERIAL AND METHODS 
VIRUS 
BVD890/256 is a clone of the American type II BVD890 strain (Bolin & Ridpath, 1992; Bolin & Ridpath, 
1995). The strain was kindly provided by Professor S.R. Bolin and, after reception, was multiplied 
once in bovine turbinate cells prior to inoculation. 
Culi 4 strain was isolated from a six-week-old Belgian blue calf, which died three days after onset of 
respiratory troubles. Postmortem examination revealed extensive haemorrhagic lesions on the 
heart, digestive tract, kidneys and cerebellum. Virus isolated from the spleen was multiplied once 
on Madin Darby Bovine Kidney (MDBK) cells prior to inoculation. 
Culi 6 strain was isolated from a three-month-old Belgian blue calf which died within a few hours of 
the appearance of dyspnoea. Postmortem findings included extensive bleeding lesions in the 
muscles, digestive tract, bladder, peritoneum, pleura and thymus. Virus isolated from the spleen 
was inoculated either as filtered spleen extract or after one multiplication cycle on MDBK cells. 
L256 strain originated from France and was isolated from the leucocytes of a 26-month-old heifer 
presenting with thrombocytopaenia associated with epistaxis, gingival, vulvar and conjunctival 
haemorrhages. L256 strain was passaged twice on MDBK cells before inoculation. 
None of the culi 4, culi 6 or L256 strains showed cytopathic effects in cell culture. Genetic typing by 
selective RT-PCR amplification of the 5 UTR end (Letellier et al., 1999) revealed that culi 4, culi 6 
and L256 belong to the genotype I. 
All viral suspensions were titrated after inoculation to confirm infectious titres of inoculums. 
Additionally, strains Osloss nc and CD87 (kindly provided by Professor E.J. Dubovi) were used for 
the seroneutralization tests. 
CALVES AND INOCULATION SCHEME 
Two successive series of nine and seven Danish crossbred calves, aged between 27 and 52 days, 
and negative for BVDV antibodies and antigen, were housed individually in isolation facilities. In 
the first series, calves were inoculated by pairs, respectively with L256, culi 4 and culi 6 strains 
passaged once in cell culture. Another pair of calves was inoculated with the culi 6 spleen extract 
while the last calf served as control. In the second series, six calves were inoculated with strain 
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Dose and route 
Series 1 2 48 L256 2 
7.6 X 106 CCID50 I.N. 
+3.6 X 106 CCID50 I.V. 
 
2 47 Culi 4 1 
 
1.7 X106 CCID50 I.N. 
 
 
2 43 Culi 6 1 9.5 X10
5
 CCID50 I.N. 
 
 
2 44 Culi 6 0 5.7 X10
3
 CCID50 I.V. 
 
 
1 51 Control – – 
Series 2 6 45 BVD890/256 1 4.2 X10
5
 CCID50 I.N. 
 
  1 39 Control – – 
Légende de la table. Viral titres were determined by titration of viral suspension after inoculation of calves. I.N.: 
intranasal route; I.V.: intravenous route. Age is in days. Cell culture passage indicates the number of passages in cell 
culture between isolation (or reception for strain BVD 890/256) and inoculation. 
CLINICAL EXAMINATION AND SAMPLING 
All calves were examined before inoculation on day -3 and day 0. After inoculation, the animals 
were examined daily. Clinical examination comprised measurement of rectal temperature, control 
of feed intake, diarrhoea, respiratory signs, behaviour, assessment of gingival, nasal and ocular 
mucosa. Blood samples and nasal swabs were taken either daily (second series) or every other day 
(first series), as shown in Table II. 
Calves presenting with severe dyspnoea, dehydration, excessive weakness or any other serious 
health deterioration were euthanased. 
 






L256 (n = 2) 
 Culi 4/1 
(n = 2) 
Culi 6/0 
(n = 2) 
 Culi 6/1 (n 
= 1) 
  Control 
(n = 1)   Control (n = 1)  
BVD890/256 
(n = 6) 
day – 3 1477 827 821 1200 1004   637 738 
day – 2 – – – – – 
 
– – 
day – 1 – – – – – 
 
586 693 
day 0 1336 779 880 1121 968 
 
561 684 
day + 1 – – – – – 
 
574 726 
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day + 2 1194 668 785 1044 886 
 
– – 
day + 3 – – – – – 
 
– – 
day + 4 1010 671 725 937 868 
 
604 578 
day + 5 896 625 715 922 781 
 
562 586 
day + 6 – – – – – 
 
509 558 
day + 7 914 732 728 983 976 
 
583 456 
day + 8 – – – – – 
 
562 322 
day + 9 895 735 726 896 719 
 
483 168 
day + 10 – – – – – 
 
401 87 
day + 11 948 788 778 964 719 
 
501 63 
day + 12 924 657 710 896 646 
 
510 97 
day + 13 – – – – – 
 
500 129 
day + 14 982 774 743 801 635 
 
499 99 
day + 15 – – – – – 
 
490 166 
day + 16 1002 748 751 708 556 
 
– – 
day + 17 – – – – – 
 
– – 
day + 18 958 731 503 717 602 
 
510 522 
day + 19 – – – – – 
 
488 635 
day + 20 – – – – – 
 
404 682 
day + 21 934 828 801 748 593   – – 
n: number of calves inoculated. For strain BVD890/256, individual values as low as 20 (x 1000/L) platelets were recorded 
on several occasions (data not shown). 
BLOOD PARAMETERS 
Within 4 h of collection, blood samples were examined for red blood cells (RBC), leucocytes, 
packed cell volume (PCV), haemoglobin, and thrombocytes. Cell counts were performed on a 
Coulter Counter ZM and thrombocytes were measured on a Technicon sorter. For all 
euthanased calves, bone marrow cytology on proximal femur aspirate (Relford, 1991) was 
undertaken to assess megacaryocyte morphology.  
 
Figure 1. Mean rectal temperature in °C (dotted line) and NS3 (p80) antigen assay (plain line). Control values 
are those from the control animal of the second series; BVD 890/256 values are mean values of all animals (n = 6) 
inoculated with strain BVD890/256. Antigen assay, expressed in optical density, was performed with Serelisa 
BVD – MD AG mono indirect test (Synbiotics). 
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Detection of viral antigens in buffy coat was performed with Serelisa BVD – MD AG mono indirect 
test (Synbiotics), according to the manufacturer’s recommendations. 
Detection of virus in nasal swabs was done by viral isolation in cell culture followed by indirect 
immunofluorescence assay, as described by Boulanger et al. (1991). In the first series, virus 
isolation tests were also performed on buffy coats. 
Seroneutralization tests : sera from all calves were tested for neutralizing antibodies against two 
references strains: Osloss nc was used as the type 1 reference strain while CD87 served as the 
type 2 reference strain. Seroneutralization tests were conducted in microtitre plates containing 
confluent monolayers of calf testicular cells. All sera were tested in duplicate in twofold 
dilution, starting at dilution 1:4, against approximately 300 CCID50 of virus. The end-point 
dilution was read by indirect immunofluorescence staining, using a pool of monoclonal 
antibodies against E0, E2 and NS3 as primary antibody (Boulanger et al., 1991).  
 
RESULTS 
For both series, control calves remained healthy throughout the experiment. No BVDV antigen 
nor BVDV antibodies were detected in either of the two controls.  
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First series (European stains): as already published elsewhere (Hamers et al., 1999), none of the 
infected calves presented any significant clinical sign and rectal temperatures always 
remained within physiological limits (Fig. 1). 
Second series (BVD890/256): all infected calves developed severe clinical signs comprising 
profuse diarrhoea starting 10 ± 0.9 days after inoculation (DAI), associated with anorexia; 
severe weakness was seen in three of the six infected calves. In four calves, diarrhoea persisted 
until euthanasia. All infected calves presented with important hyperthermia (> 40°C), as shown 
in Figure 1, starting on average 6.7 ± 1.5 DAI and persisting until euthanasia. All animals also 
developed respiratory signs comprising coughing and, in two, severe dyspnoea. For two calves, 
the deterioration in health was so severe that euthanasia was performed at 13 DAI. Another 
three calves were slaughtered for the same reason at 19 DAI while the last inoculated calf fully 
recovered one month after inoculation. The control calf was slaughtered at 19 DAI to serve as 
postmortem control. 
 
Table 3. Neutralizing antibody titre: mean of maximum individual values against Osloss nc (type 1) and CD 87 
(type 2) strains 
 
Number of calves Inoculated strain Mean highest neutralizing antibody titre  
     
   
Against Osloss nc Against CD 87 
Series 1 2 L256 7 4.75 
 
2 Culi 4 7.25 5.5 
 
2 Culi 6#1 6 7.5 
 
2 Culi 6#0 7 3 
 
1 Control <2 <2 
     
Series 2 6 BVD890/256 <2 7.9 
  1 Control <2 <2 
Antibody titres are in log2 of dilution. Sera tested from dilution 1:4 to 1:512. 
 
Figure 2. Mean thrombocyte counts according to strain inoculated: results are presented as percentages of the 
thrombocyte count at day 0. 
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None of the animals from the first series nor the control calves had any significant macroscopic 
lesion. In contrast, all five euthanased animals from the second series showed macroscopic 
lesions: four calves had signs of dehydration, three had haemorrhagic lesions on the spleen, 
heart, urinary bladder, abomasum or mesentery, and all exhibited multiple lesions of acute to 
subacute pneumonia, with oedema and consolidation. Multiple focal abscesses were observed 
in two of them. 
BLOOD PARAMETERS 
First series: blood parameters of all calves always remained within physiological limits. The 
mean thrombocyte counts are shown in Figure 2. 
Second series: with exception of calf N°15, all animals infected with BVD890/256 showed a 
severe thrombocytopaenia (< 100 000 T/mm3), starting at 10 DAI and persisting for 4.8 ± 1.3 
days (Fig. 2). With exception of calf N°15, all infected animals had a leucopenia starting at 9 DAI 
and persisting for six days. Leucopenia was principally associated with a dramatic reduction in 
neutrophils (on average, <250 neutrophils/mm3 at 10 DAI). Calf N°15, however, had a 
leucocytosis (21 000 leucocytes/mm3 at 11 DAI), probably related to the extensive purulent 
acute pneumonia. 
From about 13 DAI, three of the six infected calves presented with low PCV values (<20%) 
combined with low haemoglobin dosage (<6 g.L–1) and RBC counts. Moreover, these three calves 
were all clinically dehydrated. However, one of them did not present any macroscopic lesion of 
bleeding. Megacaryocytic morphology, evaluated by cytological analysis of bone marrow 
aspirates appeared normal. 
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First series: virus was detected neither in the buffycoat nor in nasal swabs. ELISA Detection of 
NS3 (p80) antigen always remained negative although seroconversion occurred in all animals 
(Table III). Seroneutralization tests demonstrated a rise in neutralizing antibodies starting on 
average at 16 DAI against both Osloss nc and CD87 strains. Neutralizing titres were usually lower 
against CD 87 strain than against Osloss nc strain. 
Second series: results of ELISA antigen detection in buffy coat are presented in Figure 1. BVDV 
NS3 antigen was detected in all infected calves from day 6, with a maximum at 8 DAI. Values for 
calf N°15 were very high while those of calf N°12 remained rather low. With the exception of calf 
N°12, BVDV was isolated from nasal swabs of all animals on two to eight occasions (data not 
shown). 
Neutralizing antibodies against CD87 strain were detected on average as early as 12 DAI  (Fig. 3), 
whereas seroneutralization tests remained negative against the Osloss strain.  
DISCUSSION 
The purpose of this study was to compare, through experimental inoculation, the virulence 
characters of several BVDV strains isolated from clinical haemorrhagic syndromes in Belgium, 
France and the USA. None of the European tested strains, all belonging to genotype I, produced 
significant clinical signs. Moreover, neither viraemia nor viral excretion was detected. However, 
titration of viral suspensions after inoculation and the strong seroconversion observed by 
seroneutralization tests against both type I and type II BVDV strains, confirmed that the calves had 
received infectious inoculums. This result suggests that high virulence is not an intrinsic feature of 
these strains, although isolated from cases presenting with haemorrhagic syndrome. Inoculation 
of the BVD 890/256 American strain produced, in all infected animals, such severe clinical signs that 
five of the six inoculated calves had to be euthanased. Hyperthermia, severe diarrhoea and 
respiratory signs were observed in all animals. Postmortem examination revealed extensive 
pulmonary lesions and macroscopic bleeding lesions were seen in three animals, although these 
were more discrete than expected from published reports (Corapi et al., 1989; Bolin & Ridpath, 
1992). Blood parameters were profoundly modified: thrombocytopaenia was particularly marked 
and anaemia was also observed. Antigen detection revealed an intense viraemia as well as viral 
excretion in almost all infected calves, starting at 6 DAI. A strong and rapid seroconversion was 
observed by seroneutralization tests against type II strain, but no neutralizing antibodies against 
type I strain were detected in these animals. 
Severe outbreaks of diarrhoea accompanied with thrombocytopaenia have already been observed 
with certain BVDV strains (Corapi et al., 1989; Pellerin et al., 1994; Bolin & Ridpath, 1995), whereas 
other BVDV strains have been described as responsible for severe respiratory troubles (Carman et 
al., 1998; Odeon et al., 1999). In our experiments, we observed a sequential apparition of these 
three signs in all animals infected with BVD890/256, showing that a unique hypervirulent BVDV 
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strain can induce both thrombocytopaenic and respiratory syndromes. Circumstances which 
favour the expression of a respiratory syndrome over bleeding signs remain to be investigated. 
We found that viraemia and virus shedding were easily detected in most calves inoculated with 
BVD890/256, whereas calves inoculated with the three European strains always remained below 
detection limits. Differences in viraemia and virus shedding have already been reported even 
within an homologous cytopathic and non-cytopathic pair of BVDV strains (Lambot et al., 1998). 
Moreover, neutralizing antibodies appeared earlier in the BVD890/256 inoculated calves. This could 
indicate, as observed by Bolin and Ridpath (1992), that BVD890/256 multiply in vivo at a high rate. 
Our observation that BVDV type I inoculation induces neutralizing antibodies against both virus 
types whereas that type II inoculation only induces anti type II neutralizing antibodies is consistent 
with the observation of Paton et al. (1999) who reported on fetal protection in sheep. 
Seroneutralization results should not be considered as fully predictive of immunological cross-
protection, but do indicate that BVDV type I strains could induce broader cross-protection than 
type II strains. How BVDV produces thrombocytopaenia is not yet fully understood: as previously 
reported (Rebhun et al., 1989; 1994; Bolin & Ridpath, 1992), microscopic examination did not reveal 
any significant alteration of megakaryocytes or of other marrow cells. This finding and the rapidity 
of both the initial decrease in platelet count and the subsequent recovery, suggest that 
thrombocytopaenia results from a peripheral consumption of platelets rather than from a 
production default. Other authors have shown that during viraemia, BVDV particles may be 
associated with circulating platelets (Corapi et al., 1989). This association is, however, not constant 
and may be occasionally observed with classical – non-hypervirulent – strains (Bolin & Ridpath, 
1992). On the other hand, the thrombocytopaenia phase was preceded by a peak of viraemia and 
platelet count recovery appeared to be closely related to the apparition of neutralizing antibodies 
and concomitant decrease of viraemia (Fig. 3). High titres of virus in the blood could, therefore, be 
required to produce the thrombocytopaenia. 
BVDV classical strains have been reported to intervene in respiratory troubles (Howard et al., 1989; 
Baker, 1995), possibly in association with other pathogens. In many cases, however, this does not 
seem to be accompanied by gross pathological changes (Bielefeldt-Ohmann, 1995). Moreover, 
BVDV antigens are regularly identified in healthy lungs. The severity of macroscopic lung lesions 
observed in our experiment with BVD 890/256 is consistent with the observation of others (Carman 
et al., 1998; Odeon et al., 1999) and suggests that BVDV hypervirulent strains could be, under 
certain circumstances, the primary infectious agent of severe pneumonia. Experiments under 
specific pathogen-free conditions are, however, required to demonstrate fully the lung 
pathogenicity of hypervirulent BVDV. 
To our knowledge, this study is the first attempt to reproduce experimentally the 
thrombocytopaenic syndrome with BVDV strains of European origin, and the successful 
experiment with BVD 890/256 demonstrates the validity of our experimental conditions. Our 
results indicate that the European tested strains (culi 4, culi 6 and L256) are less virulent than BVD 
890/256. This finding is supported by the sporadic number of clinical cases compared to the 
epidemic character associated with BVD 890 outbreaks, and this might be correlated to genetic 
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differences in the strains. In Europe, BVDV of low virulence may be fortuitously isolated from 
haemorrhagic syndromes but it is important to differenciate BVDV strains that are hypervirulent, 
per se, from strains that have been isolated from sporadic haemorrhagic syndromes. In a 
retrospective analysis, Broes et al. (1992) found a correlation between haemorrhagic syndrome 
and BVDV infection. It is, therefore, suggested that induction of sporadic haemorrhagic syndrome 
by BVDV type I requires the presence of a number of co-factors, whereas in the epidemic form of 
the syndrome, BVDV is the primary cause of the disease. 
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